Corient Private Wealth
TLSA icon

Corient Private Wealth’s Tiziana Life Sciences TLSA Stock Holding History

Corient Private Wealth’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.6K Hold
12,179
– – ﹤0.01% 3030
2026
Q1 		$14.3K Sell
12,179
-50
-0.4% -$71 ﹤0.01% 2794
2025
Q4 		$18.2K Hold
12,229
– – ﹤0.01% 2626
2025
Q3 		$26.4K Buy
12,229
+2,052
+20% +$3.8K ﹤0.01% 2521
2025
Q2 		$16.1K Sell
10,177
-6,300
-38% -$8.42K ﹤0.01% 2416
2025
Q1 		$17.8K Buy
+16,477
New +$16.1K ﹤0.01% 2257

Other funds holding TLSA

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
MAWAG
Mid-American Wealth Advisory Group Kansas City, Missouri $277M AUM 6.22% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Corient Private Wealth's TLSA Position: Q2 2026 in Review

Corient Private Wealth held its Tiziana Life Sciences (TLSA) position steady in Q2 2026 at 12,179 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3030.

Corient Private Wealth first reported a position in TLSA in Q1 2025 and has held it in 6 quarters since. The position peaked at $26.4K in Q3 2025. 31 funds tracked by Wall St. Rank hold TLSA as of Q2 2026.

  • Corient Private Wealth held 12,179 shares of Tiziana Life Sciences worth $15.6K as of Q2 2026.
  • Corient Private Wealth left its Tiziana Life Sciences share count unchanged in Q2 2026.
  • Tiziana Life Sciences made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #3030 holding.
  • Corient Private Wealth first reported a position in Tiziana Life Sciences in Q1 2025 and has held it in 6 quarters since.
  • Corient Private Wealth's Tiziana Life Sciences position peaked at $26.4K in Q3 2025.
  • 31 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.